Researchers at Umeå University have contributed new insights into how cancer cells protect themselves from cell death. The study provides a deeper understanding of how key proteins interact within the cell and could, in the long term, support the development of new cancer therapies.

Salk scientists have created a platform to study mitochondrial DNA mutations that lead or contribute to human disease, and generated a library of 155 mitochondrial DNA mutant cells using the platform. The platform, library, and findings will accelerate therapeutic development for mitochondrial disorders, as well as help scientists treat mitochondrial dysfunction in other diseases and conditions like cancer or aging.